{"retracted":true,"title":"Characterization of CCX140-B, an orally bioavailable antagonist of the CCR2 chemokine receptor, for the treatment of type 2 diabetes and associated complications.","url":"http://doi.org/10.1124/jpet.111.190918","journal":"The Journal of pharmacology and experimental therapeutics","update":"retracted"}
